The majority of HPA supply is coming out of Asia (3N/4N), however large scale operations are few and far between. As I've stated before, HPA is still a small niche market that has plenty of room to scale to keep up with demand.
The production of 5N at an economically viable price point will set companies apart. That is why I believe PUA (pending the acquisition) will prosper greatly.
- Forums
- ASX - By Stock
- PUA
- Ann: Investor Presentation - Revised
Ann: Investor Presentation - Revised, page-88
Featured News
Add PUA (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.98M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $46.30K | 7.718M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 214015 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 18052913 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 214015 | 0.006 |
14 | 26250317 | 0.005 |
15 | 47511921 | 0.004 |
7 | 30866666 | 0.003 |
18 | 18679779 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 18052913 | 10 |
0.008 | 7777387 | 7 |
0.009 | 5833000 | 3 |
0.010 | 18607300 | 7 |
0.011 | 5000000 | 1 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PUA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online